Objective: To evaluate the course and predictors of neuropsychiatric symptoms (NPS) and cognition in patients with de novo Parkinson disease (PD).Methods: Cross-sectional study of the cohort of de novo, untreated (at enrollment) patients with PD and healthy controls (HCs) from the Parkinson’s Progression Markers Initiative.

READ FULL ARTICLE Curated publisher From www.neurology.org